Medical Research Finder

Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

© 2026 meRfi®

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

AuthorsReferences (Sources)

meRfi® AI Chat

Cardiometabolic disease (CMD) & Gut microbiota

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Register for a free trial

Navigation

Contents

The gut microbiota plays an important role in cardiometabolic diseases (CMD) by influencing metabolic diseases such as type 2 diabetes mellitus and cardiovascular diseases. Gut microbiota and their derived metabolites (short-chain fatty acids, secondary bile acids) can influence Cardiometabolic disease (CMD).
Warmbrunn et al. 2020 Expert Rev Endocrinol Metab. 15(1): 13-27
Ratiner et al. 2022 J Diabetes 14(6): 377-393
Guiducci et al. 2023 Metabolites 13: 760
Yuan et al. 2024 Appl Microbiol Biotechnol 108: 156

Food-specific [Saturated Fatty Acids](brain://…

References (Sources)

Dietary Patterns, Gut Microbiota Remodeling, and Cardiometabolic Disease
Guiducci et al. 2023 Metabolites 13: 760
Review
Gut microbiota: a promising target against cardiometabolic diseases
Warmbrunn et al. 2020 Expert Rev Endocrinol Metab. 15(1): 13-27
Review
Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories
Stanhope et al. 2018
The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk
Wang et al. 2021f Nature Medicine 27: 333-343
The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease
Wijdeveld et al. 2020
Review
Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives
Yuan et al. 2024 Appl Microbiol Biotechnol 108: 156
Review
Time-limited diets and the gut microbiota in cardiometabolic disease
Ratiner et al. 2022 J Diabetes 14(6): 377-393
Review

AI Chat

7/1/2026

Chat with our artificial intelligence: